Skip to main content

LMR Partners LLP

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1578621 LONDON, X0

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
539,588
0.0% QoQ
Ownership
0.593%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SABS Over Time

Shares Held

Position Value (USD)

Derivatives in SABS

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
539,588
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. SABS ranks #69 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SABS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 SABSW 539,588
2026-03-31 SABSW 539,588
2025-09-30 SABSW 539,588
2025-06-30 SABSW 539,588
2025-03-31 SABSW 539,588
2024-12-31 SABSW 539,588
2024-09-30 SABSW 539,588
2024-06-30 SABSW 539,588
2024-03-31 SABSW 539,588
2023-12-31 SABSW 539,588
2023-09-30 SABSW 539,588
2023-06-30 SABSW 539,588
2023-03-31 SABSW 539,588
2022-12-31 SABSW 539,588
2022-09-30 SABSW 387,588
2022-06-30 SABSW 358,349
2022-03-31 SABSW 337,282
2021-12-31 SABSW 16,300
2021-09-30 BCYP 10,849